Developer docs
API playgroundTry for free, no card

Search company profiles

the coalition for access to prenatal screening

Full company profile

uuid00vq76w

Namestring
the coalition for access to prenatal screening
Legal namestring
The Coalition for Access to Prenatal Screening
Company typeenum
Private
Founded yearint
2017
Short descriptiontext

The Coalition for Access to Prenatal Screening is a small, privately held advocacy organization founded in 2017 that promotes access to cfDNA-based noninvasive prenatal screening and related patient and provider education.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPennsylvania Furnace, United States
HQ citystring
Pennsylvania Furnace
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
prenatal screening advocacy, noninvasive prenatal testing, cfDNA screening access, prenatal health education, genetic screening policy
Industry3 codes
1Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
CodeHLAAALAJPrimaryYes
2Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
CodeHLAAALADPrimaryNo
3Genetic, Cytogenetic & Prenatal Screening IVD
CodeHLAHAAAIPrimaryNo
NAICS code2 codes
  • Educational Support Services611710
  • Other Individual and Family Services624190
SIC code1 code
  • Services-Social Services8300
Product category
Healthcare Advocacy
Cost components3 values
Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Coalition for Access to Prenatal Screening is an advocacy organization that promotes access to cfDNA-based noninvasive prenatal screening (NIPS/NIPT) and provides related education to patients, providers, and policymakers. It functions as a coalition working to remove barriers to prenatal genetic screening and to disseminate educational resources about cell-free DNA screening options.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Advocacy for cfDNA-based noninvasive prenatal screening access
CategoryHealthcare Advocacy
Description

Coalition-level advocacy directed at healthcare systems, payers, and policymakers to expand patient access to cfDNA-based noninvasive prenatal screening (NIPS/NIPT). Targeted at clinicians, medical societies, insurers, and legislators.

2Prenatal screening education and awareness resources
CategoryHealth Education
Description

Educational content and awareness initiatives explaining cfDNA-based noninvasive prenatal screening to patients, providers, and the broader public.

No data
Peers8 records
TypeDirect peer
Description

A patient-advocacy nonprofit that drives genetic-screening awareness, education, and access — closely comparable in operating model (small coalition, focused mission around genetic-screening access) to CAPS.

TypeBroad incumbent
Description

A major sequencing and genetic-testing platform whose Verinata business pioneered cfDNA-based NIPT; relevant given its central role in the technology CAPS advocates for broader access to.

TypeDirect peer
Description

A leading U.S. nonprofit advocating for maternal and infant health, including prenatal screening access and education — directly analogous in mission (prenatal-advocacy and education) and stakeholder model to CAPS.

TypeBroad incumbent
Description

The principal U.S. professional society for OB-GYNs, setting prenatal-screening guidelines and patient-education resources; overlaps with CAPS on shaping NIPT education and access policy.

TypeDirect peer
Description

A leading NIPT and reproductive genetics diagnostics company; comparable to CAPS as a stakeholder in the same NIPT access ecosystem, even though Natera operates commercially while CAPS advocates for coverage.

TypeDirect peer
Description

A maternal-health advocacy nonprofit focused on access to quality prenatal and obstetric care; comparable to CAPS as a focused advocacy-and-education coalition operating in the prenatal space.

TypeDirect peer
Description

A nonprofit promoting quality improvement and education in obstetrics and prenatal care; comparable as a small, focused mission-driven organization working on the provider/clinical side of prenatal care.

TypeBroad incumbent
Description

A national diagnostics network offering NIPT and reproductive genetics through Integrated Genetics; comparable as a major delivery channel for the very screening CAPS advocates for.

Market position
Customer concentration

Classification, Details

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

the coalition for access to prenatal screening

Healthcare Advocacycapsprenatal.com

The Coalition for Access to Prenatal Screening is a small, privately held advocacy organization founded in 2017 that promotes access to cfDNA-based noninvasive prenatal screening and related patient and provider education.

the coalition for access to prenatal screening firmographics

Firmographics
Name
the coalition for access to prenatal screening
Legal name
The Coalition for Access to Prenatal Screening
Website
https://capsprenatal.com
Company type
Private
Founded year
2017
Headcount range
1–10 employees
Short description
The Coalition for Access to Prenatal Screening is a small, privately held advocacy organization founded in 2017 that promotes access to cfDNA-based noninvasive prenatal screening and related patient and provider education.
Ownership category
akta.pro rank

the coalition for access to prenatal screening industry classification

Industry
Product category
Healthcare Advocacy
NAICS
Educational Support Services (611710), Other Individual and Family Services (624190)
SIC
Services-Social Services (8300)
akta.pro primary industry
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)
akta.pro secondary industries
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI)

Keywords

  • Prenatal screening advocacy
  • Noninvasive prenatal testing
  • CfDNA screening access
  • Prenatal health education
  • Genetic screening policy

Where the coalition for access to prenatal screening is headquartered

Location

Headquarters

HQ city
Pennsylvania Furnace
HQ country
United States
HQ region
North America

Markets served

the coalition for access to prenatal screening business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations

the coalition for access to prenatal screening product offering

Product offering

Core offering

The Coalition for Access to Prenatal Screening is an advocacy organization that promotes access to cfDNA-based noninvasive prenatal screening (NIPS/NIPT) and provides related education to patients, providers, and policymakers. It functions as a coalition working to remove barriers to prenatal genetic screening and to disseminate educational resources about cell-free DNA screening options.

Differentiator

Problem solved

Functional benefit

Products and services

  • Advocacy for cfDNA-based noninvasive prenatal screening access Coalition-level advocacy directed at healthcare systems, payers, and policymakers to expand patient access to cfDNA-based noninvasive prenatal screening (NIPS/NIPT). Targeted at clinicians, medical societies, insurers, and legislators.
  • Prenatal screening education and awareness resources Educational content and awareness initiatives explaining cfDNA-based noninvasive prenatal screening to patients, providers, and the broader public.

Companies that use the coalition for access to prenatal screening

Customer profile

Ideal customer profiles3 records

the coalition for access to prenatal screening technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

the coalition for access to prenatal screening competitors and assessment

Company assessment

Direct peers

  • Parent Project Muscular Dystrophy (PPMD): A patient-advocacy nonprofit that drives genetic-screening awareness, education, and access — closely comparable in operating model (small coalition, focused mission around genetic-screening access) to CAPS.
  • March of Dimes: A leading U.S. nonprofit advocating for maternal and infant health, including prenatal screening access and education — directly analogous in mission (prenatal-advocacy and education) and stakeholder model to CAPS.
  • Natera: A leading NIPT and reproductive genetics diagnostics company; comparable to CAPS as a stakeholder in the same NIPT access ecosystem, even though Natera operates commercially while CAPS advocates for coverage.
  • Every Mother Counts: A maternal-health advocacy nonprofit focused on access to quality prenatal and obstetric care; comparable to CAPS as a focused advocacy-and-education coalition operating in the prenatal space.
  • Perinatal Quality Foundation: A nonprofit promoting quality improvement and education in obstetrics and prenatal care; comparable as a small, focused mission-driven organization working on the provider/clinical side of prenatal care.

Broad incumbents

  • Illumina: A major sequencing and genetic-testing platform whose Verinata business pioneered cfDNA-based NIPT; relevant given its central role in the technology CAPS advocates for broader access to.
  • American College of Obstetricians and Gynecologists (ACOG): The principal U.S. professional society for OB-GYNs, setting prenatal-screening guidelines and patient-education resources; overlaps with CAPS on shaping NIPT education and access policy.
  • Labcorp (Integrated Genetics): A national diagnostics network offering NIPT and reproductive genetics through Integrated Genetics; comparable as a major delivery channel for the very screening CAPS advocates for.

Market position

Customer concentration

the coalition for access to prenatal screening social profiles

Digital presence

the coalition for access to prenatal screening financial estimates

Financial estimate

Revenue estimate

Valuation estimate

the coalition for access to prenatal screening leadership team

Management profile

Number of profiles

Profiles1 record

the coalition for access to prenatal screening funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

the coalition for access to prenatal screening M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about the coalition for access to prenatal screening

What does the coalition for access to prenatal screening do?

The Coalition for Access to Prenatal Screening is an advocacy organization that promotes access to cfDNA-based noninvasive prenatal screening (NIPS/NIPT) and provides related education to patients, providers, and policymakers. It functions as a coalition working to remove barriers to prenatal genetic screening and to disseminate educational resources about cell-free DNA screening options.

When was the coalition for access to prenatal screening founded?

the coalition for access to prenatal screening was founded in 2017. It employs 1 to 10 people.

Where is the coalition for access to prenatal screening based?

the coalition for access to prenatal screening is headquartered in Pennsylvania Furnace, United States, in the North America region.

Who are the coalition for access to prenatal screening's main competitors?

Direct peers on record are Parent Project Muscular Dystrophy (PPMD), March of Dimes, Natera, Every Mother Counts and Perinatal Quality Foundation. Broad incumbents are Illumina, American College of Obstetricians and Gynecologists (ACOG) and Labcorp (Integrated Genetics).

Does the coalition for access to prenatal screening have an API?

No public API is recorded for the coalition for access to prenatal screening.

What industry is the coalition for access to prenatal screening in?

the coalition for access to prenatal screening's product category is Healthcare Advocacy. Its primary akta.pro industry code is HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening), with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 611710 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales